BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38404238)

  • 21. Fabrication of a phototheranostic nanoplatform for single laser-triggered NIR-II fluorescence imaging-guided photothermal/chemo/antiangiogenic combination therapy.
    Lu F; Sang R; Tang Y; Xia H; Liu J; Huang W; Fan Q; Wang Q
    Acta Biomater; 2022 Oct; 151():528-536. PubMed ID: 35970478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in Multifunctional Chemotherapeutic Prodrugs for Near-infrared Fluorescence Imaging-guided Therapy.
    Zeng J; Liu M; Li S; Cheng D; He L; Yuan L
    Chembiochem; 2023 Jun; 24(12):e202300035. PubMed ID: 36802094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Glutathione Transferase-Targeting Nitrobenzoxadiazole Compounds in Relation to PD-L1 Status in Human Melanoma Cells.
    Sciarretta F; Fulci C; Palumbo C; Rotili D; Tentori L; Graziani G; Caccuri AM
    Chemotherapy; 2019; 64(3):138-145. PubMed ID: 31639786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual-target cancer theranostic for glutathione S-transferase and hypoxia-inducible factor-1α inhibition.
    Li Z; Ding J; Chen C; Chang J; Huang B; Geng Z; Wang Z
    Chem Commun (Camb); 2017 Nov; 53(92):12406-12409. PubMed ID: 29112209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Near Infrared-Activatable Methylene Blue Polypeptide Codelivery of the NO Prodrug via π-π Stacking for Cascade Reactive Oxygen Species Amplification-Mediated Photodynamic Therapy.
    Zhang Y; Zhao P; Chen X; Xu C; Guo J; Qu X; Hu X; Gao H; Huang P; Zhang J
    ACS Appl Mater Interfaces; 2023 Mar; 15(10):12750-12765. PubMed ID: 36852940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 7-Nitro-2,1,3-benzoxadiazole derivatives, a new class of suicide inhibitors for glutathione S-transferases. Mechanism of action of potential anticancer drugs.
    Ricci G; De Maria F; Antonini G; Turella P; Bullo A; Stella L; Filomeni G; Federici G; Caccuri AM
    J Biol Chem; 2005 Jul; 280(28):26397-405. PubMed ID: 15888444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells.
    Ascione A; Cianfriglia M; Dupuis ML; Mallano A; Sau A; Pellizzari Tregno F; Pezzola S; Caccuri AM
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):419-24. PubMed ID: 19288261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An all-in-one tetrazine reagent for cysteine-selective labeling and bioorthogonal activable prodrug construction.
    He X; Li J; Liang X; Mao W; Deng X; Qin M; Su H; Wu H
    Nat Commun; 2024 Apr; 15(1):2831. PubMed ID: 38565562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy.
    Pasello M; Manara MC; Michelacci F; Fanelli M; Hattinger CM; Nicoletti G; Landuzzi L; Lollini PL; Caccuri A; Picci P; Scotlandi K; Serra M
    Anal Cell Pathol (Amst); 2011; 34(3):131-45. PubMed ID: 21673434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol: a promising new anticancer compound.
    Sha HH; Wang Z; Dong SC; Hu TM; Liu SW; Zhang JY; Wu Y; Ma R; Wu JZ; Chen D; Feng JF
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29358310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines.
    Sau A; Filomeni G; Pezzola S; D'Aguanno S; Tregno FP; Urbani A; Serra M; Pasello M; Picci P; Federici G; Caccuri AM
    Mol Biosyst; 2012 Apr; 8(4):994-1006. PubMed ID: 22068640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing the Release Efficiency of a Molecular Chemotherapeutic Prodrug by Photodynamic Therapy.
    Yuan J; Zhou QH; Xu S; Zuo QP; Li W; Zhang XX; Ren TB; Yuan L; Zhang XB
    Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202206169. PubMed ID: 35688800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GSH-Activated NIR Fluorescent Prodrug for Podophyllotoxin Delivery.
    Liu Y; Zhu S; Gu K; Guo Z; Huang X; Wang M; Amin HM; Zhu W; Shi P
    ACS Appl Mater Interfaces; 2017 Sep; 9(35):29496-29504. PubMed ID: 28758393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insights into the mechanism of JNK1 inhibition by glutathione transferase P1-1.
    De Luca A; Federici L; De Canio M; Stella L; Caccuri AM
    Biochemistry; 2012 Sep; 51(37):7304-12. PubMed ID: 22920299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel orally active water-soluble inhibitor of human glutathione transferase exerts a potent and selective antitumor activity against human melanoma xenografts.
    De Luca A; Rotili D; Carpanese D; Lenoci A; Calderan L; Scimeca M; Mai A; Bonanno E; Rosato A; Geroni C; Quintieri L; Caccuri AM
    Oncotarget; 2015 Feb; 6(6):4126-43. PubMed ID: 25595904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Near Infrared Light-Activatable Platelet-Mimicking NIR-II NO Nano-Prodrug for Precise Atherosclerosis Theranostics.
    Chai Y; Shangguan L; Yu H; Sun Y; Huang X; Zhu Y; Wang HY; Liu Y
    Adv Sci (Weinh); 2024 Jan; 11(3):e2304994. PubMed ID: 38037484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H
    Mu X; Huang Z; Feng W; Zhai M; Wang Y; Zhou D; Zhou X
    Theranostics; 2023; 13(1):267-277. PubMed ID: 36593965
    [No Abstract]   [Full Text] [Related]  

  • 38. A new nitrobenzoxadiazole-based GSTP1-1 inhibitor with a previously unheard of mechanism of action and high stability.
    Fulci C; Rotili D; De Luca A; Stella L; Morozzo Della Rocca B; Forgione M; Di Paolo V; Mai A; Falconi M; Quintieri L; Caccuri AM
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):240-247. PubMed ID: 28097896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Programmable site-specific delivery of an alkaline phosphatase-activatable prodrug and a mitochondria-targeted cyclopeptide for combination therapy in colon cancer.
    Chen H; Yao Y; Zhao X; Tan N
    Biomater Sci; 2023 Oct; 11(21):7114-7123. PubMed ID: 37671612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A gadolinium-complex-based theranostic prodrug for in vivo tumour-targeted magnetic resonance imaging and therapy.
    Yang Z; Lin H; Huang J; Li A; Sun C; Richmond J; Gao J
    Chem Commun (Camb); 2019 Apr; 55(31):4546-4549. PubMed ID: 30924831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.